Propanc Biopharma Inc (PPCB)

[elkhunter]

Dear Stockholders:



The enclosed information statement is provided on or about December [ ], 2017 to the stockholders of record on December 5, 2017 of Propanc Biopharma, Inc., a Delaware corporation (the “Company”), to advise the stockholders that our Board of Directors (the “Board”) and stockholders holding at least a majority of our voting power have authorized the following action:


1. The increase in the number of authorized shares of our common stock, par value $0.001 per share, from 100,000,000 to 400,000,000.